The use of reliever medication in asthma: The role of negative mood and symptom reports

Journal of Asthma

Volumn 40, Issue 4, 2003, Pages 357-365

  Main, Jodie ^a   Moss Morris, Rona ^a   Booth, Roger ^a   Kaptein, Ad A ^b   Kolbe, John ^a,c  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c GREEN LANE HOSPITAL   (New Zealand)

Author keywords

Asthma symptoms; Beta agonists; Compliance; Inhaler treatment; Mood; Negative affect; Relievers; Steroids

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; STEROID;

ADULT; AFFECT; AGED; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MALE; MOOD; PEAK EXPIRATORY FLOW; QUESTIONNAIRE;

ADULT; AGED; ASTHMA; BRONCHODILATOR AGENTS; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEGATIVISM; NEW ZEALAND; SELF ADMINISTRATION; SEVERITY OF ILLNESS INDEX;

EID: 0038502210     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.1081/JAS-120018635     Document Type: Article

References (31)

1. Creer TE, Levstek DA. Respiratory disorders. In: Johnston DW, Johnston M, eds. Health Psychology. Amsterdam: Elsevier, 2001:339-359.
2. Kolbe J, Fergusson W, Vamos MJG. Case-control study of severe life threatening asthma (SLTA) in adults: demographics, health care, and management of the acute attack. Thorax 2000; 55:1007-1015.
3. Creer TL, Winder JA. Respiratory disorders and their treatment. In: Kaptein AA, Creer TL, eds. Respiratory Medicine and Behavioural Research. London: Martin Dunitz, 2001.
4. Creer TL. The application of behavioral procedures to childhood asthma: current and future-perspectives. Patient Education and Counseling 1991; 17:9-22.
5. Boulet LP, Becker A, Berube D, Beveridge R, Ernst P, on behalf of the Canadian Asthma Consensus Group. Canadian asthma consensus report, 1999. CMAJ 1999; 161(Suppl 11):S1-S62.
6. Hand CH, Bradley C. Health beliefs of adults with asthma: toward an understanding of the difference between symptomatic and preventive use of inhaler treatment. J Asthma 1996; 33:331-338.
7. Bender BG, Milgrom H. Neuropsychological and psychiatric side effects of medications used to treat asthma and allergic rhinitis. In: Kaptein AA, Creer TL, eds. Respiratory Disorders and Behavioural Medicine. London: Martin Dunitz, 2002.
8. Taylor DR, Sears MR, Cockroft DW. The beta-agonist controversy. Med Clin of North Am 1996; 80:719-745.
9. Kinsman RA, Dirks JF, Dahlem NW. Noncompliance to prescribed as-needed (PRN) medication use in asthma: usage patterns and patient characteristics. J Psychosom Res 1980; 24:97-107.
10. Priel B, Heimer D, Rabinowitz B, Hendler N. Perceptions of asthma severity: the role of negative affectivity. J Asthma 1994; 31:479-484.
11. Watson D, Pennebaker JW. Health complaints, stress, and distress: exploring the central role of negative affectivity. Psychol Review 1989; 96:234-254.
12. Put C, Demedts M, Van Den Bergh O, Demyttenaere K, Verleden G. Asthma symptoms: influence of personality versus clinical status. Eur Respir J 1999; 13:751-756.
13. Jansen C, Björnsson E, Hetta J, Borman G. Anxiety and depression in relation to respiratory symptoms and asthma. Am J Respir Crit Care Med 1994; 149:930-934.
14. Leventhal H, Leventhal EA, Cameron L. Representations, procedures, and affect in illness self-regulation: a perceptual-cognitive model. In: Baum A, Revenson TA, Singer JE, eds. Handbook of Health Psychology. Mahwah, NJ: Lawrence Erlbaum Associates, 2001:19-47.
15. Rietveld S, Prins PJM. The relationship between negative emotions and acute subjective and objective symptoms of childhood asthma. Psychol Med 1998; 28:407-415.
16. Rietveld S, Brosschot JF. Current perspectives on symptom perception in asthma: a biomedical and psychological review. Int J of Beh Med 1999; 6:120-134.
17. Dirks JF, Schraa JC, Robinson SK. Patient mislabeling of symptoms: implications for patient-physician communication and medical outcome. Int J of Psychiatry Med 1982; 12:15-27.
18. Moss-Morris R, Weinman J, Petrie KJ, Horne R, Cameron LD, Buick D. The revised illness perception questionnaire (IPQ-R). Psychology and Health 2002; 17:1-16.
19. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 1988; 54:1063-1070.
20. Creer TL, Levstek DA, Winder JA. Home monitoring of lung function measures. Lung Biology in Health and Disease 1998; 113:117-146.
21. Kolbe J, Richards G, Fenwick J, Rea H. Relationship of non-specific airway hyperresponsiveness (AHR) to measures of peak expiratory flow (PEF) variability. Aus NZ J Med 1996; 26:59-65.
22. American Thoracic Society. Standardisation of spirometry. 1994 Update. Am J Respir Crit Care Med 1995; 152:1107-1132.
23. Quonjer PH. Standardisation of lung function testing. Report of working party. European Community for Coal and Steel Recommendations. Bull Eur Physiopothol Respir 1983; 19(Suppl 5):1-93.
24. Holmbeck GN. Towards terminological, conceptual, and statistical clarity in the study of mediators and moderators: examples from the child-clinical and paediatric psychology literatures. J Consul Clin Psychol 1997; 65:599-610.
25. Rietveld S, Kolk AM, Prins PJM. The influence of lung function information on self-reports of dyspnoea by children with asthma. J Pediatric Psychology 1996; 21:367-377.
26. Grampian Study of Integrated Care. Effectiveness of routine self monitoring of peak flow and patients with asthma. BMJ 1994; 308:564-567.
27. Charlton I, Charlton G, Broomfield J, Mullee MA. Evaluation of peak flow and symptoms only self-management plans for control of asthma in general practice. BMJ 1990; 301:1355-1359.
28. Turner MO, Taylor D, Bennett A, Fitzgerald MJ. A randomised trial comparing peak expiratory flow and symptom self-management plans for patients with asthma attending a primary care clinic. Am J Respir Crit Care Med 1998; 157:540-546.
29. Verschelden P, Cartier A, L'Archeveque J, Trudeau C, Malo J-L. Compliance with and accuracy of daily self-assessment of peak expiratory flows (PEF) in asthmatic subjects over a 3 month period. Eur Respir J 1996; 9:880-885.
30. Cóte J, Cartier A, Malo J-L, Rouleau M, Boulet L-P. Compliance with peak expiratory flow monitoring in home management of asthma. Chest 1998; 113:968-972.
31. Gonder-Frederick L, Cox D. Symptom perception, symptom beliefs, and blood glucose discrimination in the self-treatment of insulin-dependent diabetes. In: Skelton JA, Croyle RT, eds. Mental Representations in Health and Illness. New York: Springer-Verlag, 1991:220-246.